(Q32054940)

6 July 2017

title

Lipoprotein(a) further increases the risk of coronary events in men with high global cardiovascular risk (English)

1 reference

6 July 2017

0 references

1 reference

1 reference

von Eckardstein A

1

1 reference

6 July 2017

Schulte H

series ordinal

2

1 reference

6 July 2017

Cullen P

series ordinal

3

1 reference

6 July 2017

Assmann G

series ordinal

4

1 reference

6 July 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

Journal of the American College of Cardiology

6 July 2017

published in

1 reference

6 July 2017

volume

37

1 reference

6 July 2017

issue

2

1 reference

6 July 2017

page(s)

434-439

1 reference

Evaluating novel cardiovascular risk factors: can we better predict heart attacks?

6 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901126-8

7 January 2021

Coronary heart disease: reducing the risk: a worldwide view. International Task Force for the Prevention of Coronary Heart Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901126-8

7 January 2021

Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901126-8

7 January 2021

Genetic architecture and evolution of the lipoprotein(a) trait

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901126-8

7 January 2021

Lipoprotein(a): intrigues and insights

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901126-8

7 January 2021

Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901126-8

7 January 2021

Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901126-8

7 January 2021

Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901126-8

7 January 2021

Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901126-8

7 January 2021

Lp(a) lipoprotein level predicts survival and major coronary events in the Scandinavian Simvastatin Survival Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901126-8

7 January 2021

Lipoprotein(a) as a risk predictor for cardiac mortality in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901126-8

7 January 2021

Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901126-8

7 January 2021

A prospective study of lipoprotein(a) and the risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901126-8

7 January 2021

Is lipoprotein(a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901126-8

7 January 2021

Is lipoprotein(a)-cholesterol a better predictor of vascular disease events than total lipoprotein(a) mass? A nested case control study from the West of Scotland Coronary Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901126-8

7 January 2021

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901126-8

7 January 2021

Lipoprotein(a) in stored plasma samples and the ravages of time. Why epidemiological studies might fail

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901126-8

7 January 2021

The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901126-8

7 January 2021

Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901126-8

7 January 2021

Lipoprotein(a) interactions with lipid and non-lipid risk factors in patients with early onset coronary artery disease: results from the NHLBI Family Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901126-8

7 January 2021

Lipoprotein(a) is an independent risk factor for coronary artery disease in NIDDM patients in South India

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901126-8

7 January 2021

Lack of association of lipoprotein (a) with coronary heart disease in Spaniard type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901126-8

7 January 2021

Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901126-8

7 January 2021

10.1016/S0735-1097(00)01126-8

Identifiers

DOI

1 reference

6 July 2017

1 reference